Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > OK Providers

Dr. Scott W. Cole, MD

(Dr. Scott Cole, MD)

(49 Ratings)

Specializes in: Medical Oncology, Adult Oncology and Adult Hematology

University of Oklahoma College of Medicine

12697 E 51st Street
Tulsa, OK 74146

(918) 505-3200

Dr. Scott W. Cole, MD is a medical oncologist in Tulsa, OK specializing in medical oncology, adult oncology and adult hematology. He graduated from University of Oklahoma College of Medicine. Dr. Scott W. Cole, MD is affiliated with Saint Francis Health System, Ascension and Ascension St. John Medical Center.

Office Locations

12697 E 51st Street
Tulsa, OK 74146

open_in_new

Noteworthy Medicare Patient Procedures Performed by Dr. Scott W. Cole, MD in 2023

Click on any procedure below to see further details on volume and pricing among Medicare patients.

Top 5%

By Volume:

creatinine blood test

CT scan

joint scan

lab tests

lactate dehydrogenase test

microalbumin urine test

musculoskeletal imaging

nuclear scan

pelvic CT scan

phlebotomy for lab tests

phosphorus blood test

By Affordability:

abdominal CT scan

albumin test

antineoplastic hormone therapy

carcinoembryonic antigen test

coagulation tests

creatinine blood test

kidney function tests

lactate dehydrogenase test

liver function tests

lower extremity venous ultrasound

lower extremity venous duplex

magnesium test

metabolic panel

microalbumin test

microalbumin urine test

MRI

nuclear scan

pelvic CT scan

phosphorus blood test

phosphorus test

prostate-specific antigen test

prothrombin time test

quantitative Ig tests

reticulocyte count

thyroid blood test

thyroid function tests

venous duplex ultrasound

venous ultrasound

In 2023, among providers in related specialties within Oklahoma, Dr. Scott W. Cole, MD performed more abdominal CT scan, blood draw, bone scan, chest CT scan, creatinine blood test, CT scan, joint scan, lab tests, lactate dehydrogenase (LDH) test, microalbumin urine test, musculoskeletal imaging, nuclear scan, pelvic CT scan, phlebotomy for lab tests, phosphorus blood test, thyroid blood test, total IgA test, total IgG test, total PSA test, and uric acid blood test procedures for Medicare patients than 95% of them and he also had a list price for abdominal CT scan, albumin test, antineoplastic hormone therapy, blood count tests, bone scan, brain MRI, cancer antigen tests, carcinoembryonic antigen (CEA) test, coagulation (blood clotting) tests, creatinine blood test, creatinine test, duplex ultrasound, flow cytometry, hormone therapy, IgA test, IgD test, IgG test, IgM test, immunoglobulin tests, iron tests, joint scan, kidney function tests, lactate dehydrogenase (LDH) test, liver function tests (LFTs), lower extremity (leg) venous ultrasound, lower extremity venous duplex, magnesium test, metabolic panel, microalbumin test, microalbumin urine test, MRI (magnetic resonance imaging), nuclear scan, pelvic CT scan, phosphorus blood test, phosphorus test, prostate-specific antigen (PSA) test, prothrombin time (PT) test, quantitative Ig tests, reticulocyte count (immature red blood cell count), thyroid blood test, thyroid function tests, total IgA test, total IgG test, total PSA test, uric acid blood test, uric acid test, urinalysis, vascular studies, vascular ultrasound, venous duplex ultrasound, and venous ultrasound that was lower than the list prices billed to Medicare by 95% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Top 10%

By Affordability:

complete blood count

port flush

In 2023, Dr. Scott W. Cole, MD had a list price for complete blood count (CBC), and port flush that was lower than the list prices billed to Medicare by 90% of providers in related specialties within Oklahoma. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Top 25%

By Volume:

biological response modifier therapy

intravenous chemotherapy

intravenous infusion

port flush

By Affordability:

blood draw

blood draw for lab tests

blood tests

CT scan

intravenous infusion therapy

intravenous infusion

phlebotomy for lab tests

urine tests

venipuncture

In 2012, among providers in related specialties within Oklahoma, Dr. Scott W. Cole, MD performed more biological response modifier (BRM) therapy, intravenous (IV) chemotherapy, intravenous (IV) infusion, and port flush procedures for Medicare patients than 75% of them and he also had a list price for blood draw, blood draw for lab tests, blood tests, CT scan, intravenous infusion therapy, intravenous (IV) infusion, phlebotomy for lab tests, urine tests, and venipuncture (phlebotomy) that was lower than the list prices billed to Medicare by 75% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

The top procedures that Dr. Scott W. Cole, MD treated as a medical oncologist in Tulsa, OK during 2012 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Scott W. Cole, MD for Medicare patients.

abdominal imaging	98
biological response modifier (BRM) therapy	262
blood draw	790
chemotherapy	262
CT scan	189
doctor visit	1017
hospital care	242
inpatient care	242
lab tests	6889
minimally invasive procedures	320
pelvic imaging	98
port flush	19
thoracic (chest) imaging	91
thyroid function tests	26

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. Scott W. Cole, MD treated as a medical oncologist in Tulsa, OK during 2013 were lab tests, blood draw, inpatient care and hospital care.

Volume of procedures performed by Dr. Scott W. Cole, MD for Medicare patients.

abdominal imaging	109
biological response modifier (BRM) therapy	248
blood draw	559
chemotherapy	248
CT scan	219
doctor visit	1206
hospital care	364
inpatient care	364
lab tests	5361
minimally invasive procedures	332
pelvic imaging	109
port flush	16
thoracic (chest) imaging	123
thyroid function tests	17
X-rays	13

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Scott W. Cole, MD.

**Gender**
Male	223
Female	370

**Ethnicity**
Non-Hispanic White	497
Black	0
Hispanic	0
Asian	0
Other	0
Native American	61

**Age**
From 65 to 74	291
From 75 to 84	189
85 and over	54
Less than 65	59

Conditions of Medicare patients treated by Dr. Scott W. Cole, MD in 2013

Hypertension	71
High Cholesterol	47
Stroke	4
Ischemic Heart Disease	34
Depression	24
Chronic Kidney Disease	31
Asthma	7
Osteoperosis	11
Atrial Fibrilation	9
Heart Failure	21
Chronic Obstructive Pulmonary Disease	18
Diabetes	32
Dementia	7
Cancer	54

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. Scott W. Cole, MD treated as a medical oncologist in Tulsa, OK during 2014 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Scott W. Cole, MD for Medicare patients.

abdominal imaging	123
biological response modifier (BRM) therapy	381
blood draw	666
brain imaging (neuroimaging)	20
chemotherapy	381
CT scan	273
doctor visit	1403
hormone therapy	31
hospital care	167
inpatient care	167
lab tests	4583
minimally invasive procedures	458
MRI (magnetic resonance imaging)	20
pelvic imaging	123
port flush	52
preventive care	16
radiation therapy	200
thoracic (chest) imaging	150
thyroid function tests	29
vaccines	16

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Scott W. Cole, MD.

**Gender**
Male	453
Female	754

**Ethnicity**
Non-Hispanic White	1017
Black	60
Hispanic	0
Asian	0
Other	0
Native American	108

**Age**
From 65 to 74	570
From 75 to 84	399
85 and over	108
Less than 65	130

Conditions of Medicare patients treated by Dr. Scott W. Cole, MD in 2014

Hypertension	67
High Cholesterol	43
Stroke	4
Ischemic Heart Disease	32
Depression	23
Chronic Kidney Disease	28
Asthma	7
Osteoperosis	9
Atrial Fibrilation	11
Heart Failure	21
Chronic Obstructive Pulmonary Disease	19
Diabetes	30
Dementia	7
Cancer	53

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. Scott W. Cole, MD treated as a medical oncologist in Tulsa, OK during 2015 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Scott W. Cole, MD for Medicare patients.

abdominal imaging	308
biological response modifier (BRM) therapy	689
blood draw	1575
brain imaging (neuroimaging)	45
chemotherapy	689
CT scan	669
doctor visit	2021
hormone therapy	108
hospital care	123
inpatient care	123
lab tests	15061
minimally invasive procedures	835
MRI (magnetic resonance imaging)	45
neck imaging	24
pelvic imaging	279
thoracic (chest) imaging	337
thyroid function tests	59
ultrasound (sonogram)	17
vascular procedures	17

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Scott W. Cole, MD.

**Gender**
Male	602
Female	1090

**Ethnicity**
Non-Hispanic White	1468
Black	38
Hispanic	0
Asian	0
Other	0
Native American	142

**Age**
From 65 to 74	788
From 75 to 84	576
85 and over	146
Less than 65	182

Conditions of Medicare patients treated by Dr. Scott W. Cole, MD in 2015

Hypertension	68
High Cholesterol	45
Stroke	8
Ischemic Heart Disease	32
Depression	22
Chronic Kidney Disease	28
Asthma	13
Osteoperosis	8
Atrial Fibrilation	9
Heart Failure	18
Chronic Obstructive Pulmonary Disease	17
Diabetes	29
Dementia	6
Cancer	58

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

The top procedures that Dr. Scott W. Cole, MD treated as a medical oncologist in Tulsa, OK during 2016 were lab tests, blood draw, CT scan and minimally invasive procedures.

Volume of procedures performed by Dr. Scott W. Cole, MD for Medicare patients.

abdominal imaging	354
biological response modifier (BRM) therapy	376
blood draw	1894
brain imaging (neuroimaging)	37
chemotherapy	376
CT scan	727
doctor visit	2102
hormone therapy	90
hospital care	67
inpatient care	67
lab tests	18900
minimally invasive procedures	440
MRI (magnetic resonance imaging)	53
neck imaging	16
pelvic imaging	338
port flush	61
thoracic (chest) imaging	393
thyroid function tests	89
ultrasound (sonogram)	21
vascular procedures	21
X-rays	20

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Scott W. Cole, MD.

**Gender**
Male	363
Female	635

**Ethnicity**
Non-Hispanic White	845
Black	32
Hispanic	0
Asian	0
Other	0
Native American	99

**Age**
From 65 to 74	485
From 75 to 84	331
85 and over	80
Less than 65	102

Conditions of Medicare patients treated by Dr. Scott W. Cole, MD in 2016

Hypertension	69
High Cholesterol	46
Stroke	4
Ischemic Heart Disease	31
Depression	21
Chronic Kidney Disease	34
Asthma	19
Osteoperosis	9
Atrial Fibrilation	9
Heart Failure	17
Chronic Obstructive Pulmonary Disease	20
Diabetes	30
Dementia	8
Cancer	56

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

The top procedures that Dr. Scott W. Cole, MD treated as a medical oncologist in Tulsa, OK during 2017 were lab tests, blood draw, CT scan and thoracic (chest) imaging.

Volume of procedures performed by Dr. Scott W. Cole, MD for Medicare patients.

abdominal imaging	286
biological response modifier (BRM) therapy	107
blood draw	1376
brain imaging (neuroimaging)	50
chemotherapy	107
CT scan	558
doctor visit	1720
hormone therapy	18
hospital care	92
inpatient care	92
lab tests	15634
minimally invasive procedures	160
MRI (magnetic resonance imaging)	65
pelvic imaging	271
port flush	120
thoracic (chest) imaging	315
thyroid function tests	56
ultrasound (sonogram)	16
vascular procedures	16
X-rays	28

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Scott W. Cole, MD.

**Gender**
Male	400
Female	612

**Ethnicity**
Non-Hispanic White	850
Black	33
Hispanic	15
Asian	0
Other	0
Native American	98

**Age**
From 65 to 74	505
From 75 to 84	325
85 and over	82
Less than 65	100

Conditions of Medicare patients treated by Dr. Scott W. Cole, MD in 2017

Hypertension	73
High Cholesterol	44
Stroke	4
Ischemic Heart Disease	33
Depression	23
Chronic Kidney Disease	36
Asthma	7
Osteoperosis	9
Atrial Fibrilation	9
Heart Failure	19
Chronic Obstructive Pulmonary Disease	18
Diabetes	31
Dementia	9
Cancer	57

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

The top procedures that Dr. Scott W. Cole, MD treated as a medical oncologist in Tulsa, OK during 2018 were lab tests, blood draw, CT scan and thoracic (chest) imaging.

Volume of procedures performed by Dr. Scott W. Cole, MD for Medicare patients.

abdominal imaging	224
biological response modifier (BRM) therapy	144
blood draw	1614
brain imaging (neuroimaging)	39
chemotherapy	144
CT scan	488
doctor visit	1742
hormone therapy	29
hospital care	41
inpatient care	41
lab tests	16050
minimally invasive procedures	207
MRI (magnetic resonance imaging)	39
musculoskeletal imaging	23
nuclear scan	23
pelvic imaging	224
port flush	97
thoracic (chest) imaging	264
thyroid function tests	135
ultrasound (sonogram)	20
vascular procedures	20

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Scott W. Cole, MD.

**Gender**
Male	415
Female	615

**Ethnicity**
Non-Hispanic White	866
Black	28
Hispanic	15
Asian	0
Other	0
Native American	98

**Age**
From 65 to 74	512
From 75 to 84	341
85 and over	82
Less than 65	95

Conditions of Medicare patients treated by Dr. Scott W. Cole, MD in 2018

Hypertension	73
High Cholesterol	51
Stroke	4
Ischemic Heart Disease	35
Depression	24
Chronic Kidney Disease	35
Asthma	7
Osteoperosis	9
Atrial Fibrilation	10
Heart Failure	21
Chronic Obstructive Pulmonary Disease	19
Diabetes	31
Dementia	8
Cancer	54

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. Scott W. Cole, MD treated as a medical oncologist in Tulsa, OK during 2019 were lab tests, blood draw, CT scan and thoracic (chest) imaging.

Volume of procedures performed by Dr. Scott W. Cole, MD for Medicare patients.

abdominal imaging	241
biological response modifier (BRM) therapy	110
blood draw	1888
brain imaging (neuroimaging)	37
chemotherapy	110
CT scan	475
doctor visit	1588
hospital care	70
inpatient care	70
lab tests	17778
minimally invasive procedures	145
MRI (magnetic resonance imaging)	49
musculoskeletal imaging	26
nuclear scan	26
pelvic imaging	229
port flush	54
thoracic (chest) imaging	246
thyroid function tests	235
ultrasound (sonogram)	12
vascular procedures	12

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Scott W. Cole, MD.

**Gender**
Male	449
Female	623

**Ethnicity**
Non-Hispanic White	926
Black	33
Hispanic	14
Asian	0
Other	0
Native American	75

**Age**
From 65 to 74	526
From 75 to 84	353
85 and over	86
Less than 65	107

Conditions of Medicare patients treated by Dr. Scott W. Cole, MD in 2019

Hypertension	72
High Cholesterol	54
Stroke	5
Ischemic Heart Disease	36
Depression	26
Chronic Kidney Disease	37
Asthma	6
Osteoperosis	9
Atrial Fibrilation	12
Heart Failure	22
Chronic Obstructive Pulmonary Disease	19
Diabetes	30
Dementia	10
Cancer	56

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

The top procedures that Dr. Scott W. Cole, MD treated as a medical oncologist in Tulsa, OK during 2020 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Scott W. Cole, MD for Medicare patients.

abdominal imaging	146
biological response modifier (BRM) therapy	361
blood draw	1889
brain imaging (neuroimaging)	22
chemotherapy	361
CT scan	322
doctor visit	1660
hormone therapy	74
hospital care	17
inpatient care	17
lab tests	17692
minimally invasive procedures	480
MRI (magnetic resonance imaging)	22
pelvic imaging	146
port flush	89
thoracic (chest) imaging	176
thyroid function tests	288
ultrasound (sonogram)	14
vascular procedures	14

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Scott W. Cole, MD.

**Gender**
Male	589
Female	822

**Ethnicity**
Non-Hispanic White	1190
Black	50
Hispanic	0
Asian	0
Other	25
Native American	125

**Age**
From 65 to 74	691
From 75 to 84	468
85 and over	117
Less than 65	135

Conditions of Medicare patients treated by Dr. Scott W. Cole, MD in 2020

Hypertension	70
High Cholesterol	51
Stroke	3
Ischemic Heart Disease	36
Depression	28
Chronic Kidney Disease	39
Asthma	5
Osteoperosis	9
Atrial Fibrilation	11
Heart Failure	21
Chronic Obstructive Pulmonary Disease	19
Diabetes	31
Dementia	8
Cancer	52

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

The top procedures that Dr. Scott W. Cole, MD treated as a medical oncologist in Tulsa, OK during 2021 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Scott W. Cole, MD for Medicare patients.

abdominal imaging	165
biological response modifier (BRM) therapy	449
blood draw	1567
brain imaging (neuroimaging)	21
chemotherapy	449
CT scan	376
doctor visit	1530
hormone therapy	56
hospital care	37
inpatient care	37
lab tests	16051
minimally invasive procedures	572
MRI (magnetic resonance imaging)	21
musculoskeletal imaging	30
nuclear scan	30
pelvic imaging	165
port flush	109
thoracic (chest) imaging	211
thyroid function tests	268
ultrasound (sonogram)	20
vascular procedures	20

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Scott W. Cole, MD.

**Gender**
Male	648
Female	910

**Ethnicity**
Non-Hispanic White	1341
Black	54
Hispanic	13
Asian	12
Other	33
Native American	105

**Age**
From 65 to 74	772
From 75 to 84	529
85 and over	125
Less than 65	132

Conditions of Medicare patients treated by Dr. Scott W. Cole, MD in 2021

Hypertension	68
High Cholesterol	48
Stroke	4
Ischemic Heart Disease	35
Depression	26
Chronic Kidney Disease	37
Asthma	6
Osteoperosis	9
Atrial Fibrilation	12
Heart Failure	20
Chronic Obstructive Pulmonary Disease	17
Diabetes	29
Dementia	8
Cancer	48

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

The top procedures that Dr. Scott W. Cole, MD treated as a medical oncologist in Tulsa, OK during 2022 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Scott W. Cole, MD for Medicare patients.

abdominal imaging	128
biological response modifier (BRM) therapy	432
blood draw	1639
brain imaging (neuroimaging)	29
chemotherapy	432
CT scan	298
doctor visit	1324
hormone therapy	53
lab tests	17173
minimally invasive procedures	556
MRI (magnetic resonance imaging)	29
musculoskeletal imaging	12
nuclear scan	12
pelvic imaging	128
port flush	132
thoracic (chest) imaging	170
thyroid function tests	310
ultrasound (sonogram)	25
vascular procedures	25

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Scott W. Cole, MD.

**Gender**
Male	576
Female	819

**Ethnicity**
Non-Hispanic White	1205
Black	43
Hispanic	0
Asian	0
Other	28
Native American	94

**Age**
From 65 to 74	676
From 75 to 84	510
85 and over	104
Less than 65	105

Conditions of Medicare patients treated by Dr. Scott W. Cole, MD in 2022

Hypertension	75
High Cholesterol	64
Stroke	6
Ischemic Heart Disease	26
Depression	27
Chronic Kidney Disease	26
Asthma	9
Osteoperosis	14
Atrial Fibrilation	20
Heart Failure	19
Chronic Obstructive Pulmonary Disease	21
Diabetes	29
Dementia	5
Cancer	59

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2022

Volume of procedures performed by Dr. Scott W. Cole, MD for Medicare patients.

The highest averages for the top procedures that Dr. Scott W. Cole, MD treated as a medical oncologist in Tulsa, OK were lab tests, blood draw, CT scan and minimally invasive procedures.

abdominal imaging	198
biological response modifier (BRM) therapy	323
blood draw	1405
brain imaging (neuroimaging)	33
chemotherapy	323
CT scan	417
doctor visit	1573
hormone therapy	57
hospital care	122
inpatient care	122
lab tests	13742
minimally invasive procedures	409
MRI (magnetic resonance imaging)	38
musculoskeletal imaging	22
neck imaging	20
nuclear scan	22
pelvic imaging	191
preventive care	16
radiation therapy	200
thoracic (chest) imaging	225
thyroid function tests	137
ultrasound (sonogram)	18
vaccines	16
vascular procedures	18
X-rays	20

Average Medicare Patient Data From 2012 - 2022

Information about Medicare patients treated by Dr. Scott W. Cole, MD.

**Gender**
Male	428
Female	659

**Ethnicity**
Black / African American	33
Asian / Pacific Islander	1
Non-Hispanic White	927
Hispanic	5
Native American / Alaskan Native	91
Other	7

**Age**
75 to 84	365
85 and over	89
Less than 65	104
65 to 74	528

Average of Total of Conditions of Medicare patients treated by Dr. Scott W. Cole, MD From 2012 - 2022

The highest averages of the most common conditions of Medicare patients that Dr. Scott W. Cole, MD treated were hypertension, cancer, high cholesterol and chronic kidney disease.

Hypertension	64
High Cholesterol	44
Stroke	4
Ischemic Heart Disease	30
Depression	22
Chronic Kidney Disease	30
Asthma	7
Osteoporosis	8
Heart Failure	18
Chronic Obstructive Pulmonary Disease	17
Diabetes	27
Atrial Fibrillation	10
Cancer	49
Dementia	6

Education & Training

Dr. Scott W. Cole, MD graduated from University of Oklahoma College of Medicine. He completed residency at University of Alabama Affiliated Hospitals. He is certified by the The American Board of Internal Medicine - Hematology The American Board of Internal Medicine - Hospice and Palliative Medicine The American Board of Internal Medicine - Medical Oncology and has a state license in Oklahoma.

Medical School: University of Oklahoma College of Medicine

Residency: University of Alabama Affiliated Hospitals

Board Certification: The American Board of Internal Medicine - Hematology The American Board of Internal Medicine - Hospice and Palliative Medicine The American Board of Internal Medicine - Medical Oncology

Licensed In: Oklahoma

Affiliations & Hospitals

Dr. Scott W. Cole, MD is associated with these hospitals and organizations:

Saint Francis Health System

Ascension

Ascension St. John Medical Center

Ratings & Reviews

Dr. Scott W. Cole, MD has an exceptional overall rating with an average of 4.9 out of 5 stars based on 49 ratings. We collect ratings and reviews of Dr. Scott W. Cole, MD from all over the web to help you find the right in Tulsa, OK.

4.9

Overall Rating

(49 Ratings)

Leave a Review

Reviews Left On DocSpot

Overall Rating: 5.0 2023-10-31

It's been a while since I have seen Dr. Cole, but anytime I think about my fight with cancer I can't help but thank him. He is a wonderful, WONDERFUL doctor. He cares deeply about his patients and their families, he wants what is best for them physically, emotionally and mentally. He wanted to make sure I fully understood my diagnosis and the protocol he had outlined for me. The rest of his team follow his example, wonderful people.

General Payments

These charts describe general payments received by Dr. Scott W. Cole, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Bayer HealthCare Pharmaceuticals Inc.	$7,820 Nubeqa $5,997	Vitrakvi $1,774	Nexavar $34	Stivarga $15
Merrimack Pharmaceuticals, Inc.	$5,456 ONIVYDE $5,456
Heron Therapeutics, Inc.	$5,293 SUSTOL $3,993	HTX-011 $1,300
Exelixis Inc.	$4,333 Cabometyx $3,085	COMETRIQ $1,248
Celgene Corporation	$3,491 Revlimid $3,342	Abraxane $113	Reblozyl $19	$17
Other	$7,603 IMBRUVICA $2,401	IBRANCE $569	Enhertu $384	OPDIVO $250	LYNPARZA $217	Other $3,782

**Types of Payments**
Consulting Fee	$20,510
Food and Beverage	$6,170
Travel and Lodging	$4,878
Education	$1,238
Honoraria	$1,200

Research Payments

Dr. Scott W. Cole, MD has received 421 research payments totaling $899,167.

Biography

Dr. Scott Cole specializes in adult hematology, adult oncology, and medical oncology. Dr. Cole's professional affiliations include Ascension and Saint Francis Health System. He graduated from the University of Oklahoma College of Medicine and then he performed his residency at a hospital affiliated with the University of Alabama. On average, patients gave him a rating of 5.0 stars (out of 5).